Ginkgo and Huperzine with electrical stimulation for brain injury cognitive problems
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study tests whether a combination of Ginkgo Leaf Dropping Pills, Huperzine A injection, and median nerve electrical stimulation can improve cognitive function in people who have thinking or memory problems after a brain injury. The trial aims to see if this treatment is safe and effective compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have cognitive problems (e.g., memory, thinking) that resulted from a brain injury.
- You must not have other brain diseases (other than the current injury).
- You must not have severe underlying medical conditions or unstable vital signs.
- You must be conscious and able to cooperate with cognitive testing.
- You must not be allergic to the study drugs or have conditions that prevent their use.
- You must not have conditions that prevent the use of electrical stimulation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stimulating a nerve in the wrist (median nerve) can help improve thinking and memory problems in people who have had a recent traumatic brain injury. It is for adults with moderate injuries who have trouble with memory and thinking.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
This study tests whether taking a ginkgo biloba extract supplement can help improve thinking and memory after a recent stroke. People who participate will receive the extract and have their cognitive function assessed with simple tests.
This study tests if a gentle, noninvasive nerve stimulation (on the neck) combined with computerized thinking exercises can help people recovering from a traumatic brain injury improve memory and attention. It is for adults currently in inpatient rehab who can use a keyboard and are medically stable.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This study tests an investigational drug called Huperzine A, given as an injection after treatment for a bleeding brain aneurysm, to see if it can help prevent or reduce thinking and memory problems that sometimes occur after surgery or procedures.
Hear when a new Cognitive Impairment After Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.